Clinical Trial Update: A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR) [Phase 2]

View source ↗

Summary

A Phase II study evaluating intranasal GSK256066 in combination with fluticasone propionate for seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)
• GSK256066

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Seasonal | Phase 2 | Status: COMPLETED